SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Novartis India Ltd

BSE: 500672 NSE: NOVARTIND ISIN: INE234A01025
  |   Sector:  Miscellaneous   |   Industry:  Trading

Snapshot

Q.1 Which industry/sub-sector does Novartis India Ltd belong to?
Novartis India Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.
Q.2 Is Novartis India Ltd a good quality company?
Novartis India Ltd is a average quality company, based on a somewhat consistent 10 year financial track record.
Q.3 Is Novartis India Ltd undervalued or overvalued?
Novartis India Ltd appears Overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Novartis India Ltd a good buy now?
Novartis India Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Novartis India Ltd?
Novartis India Ltd revenue growth is 6.3% for FY-2025 , which is above its 5 year CAGR of -4.1% , indicating faster growth.
Q.2 Gross Profit margin of Novartis India Ltd?
Novartis India Ltd Gross profit margin which is the profit after deduction of direct costs, is 34% for FY-2025 , which is above its 5 year median of 29.4% , indicating increasing margins.
Q.3 Operating Profit Margin of Novartis India Ltd?
Novartis India Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 25.74% for FY-2025 , which is above its 5 year median of 17.46% indicating increasing margins.
Q.4 Net Profit Margin of Novartis India Ltd?
Novartis India Ltd Net Profit Margin is 28.32% for FY-2025 , is above with its 5 year median of 25.42%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 34 29.4
Operating Profit Margin 25.74 17.46
Net Profit Margin 28.32 25.42
Q.5 Return on Asset of Novartis India Ltd?
Novartis India Ltd Return on Asset is 5.35%, which is above its 5 year historical median of 4.35%, indicating improved asset utilization efficiency.
Q.6 Return on Equity (ROE) of Novartis India Ltd?
Novartis India Ltd Return on equity is 13.19% for FY-2025 , which is above its historical median of 11.21%, indicating the business is making better use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Novartis India Ltd?
Novartis India Ltd Return on capital employed is 17.15% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation.
Q.8 Cash conversion cycle of Novartis India Ltd?
Novartis India Ltd Cash conversion cycle is -7 days, below its historical median of 1 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.21 0.21
ROE 13.19 11.21
ROCE 17.15 15.96
Cash Conversion Cycle -7 days 1 days
Q.9 Debt to Equity ratio of Novartis India Ltd?
Novartis India Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.03 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Novartis India Ltd?
Novartis India Ltd Debt to cash flow from operations is 0 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Novartis India Ltd?
Promoters hold 70.68% of the Novartis India Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Novartis India Ltd vs industry peers?
Novartis India Ltd revenue CAGR is -4.06% , compared to the industry median CAGR of 0% , indicating stable growth and maintaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 356.3 13.3
Gross Profit 121 0.4
Operating Profit 91 0
Net Profit 101 0.3
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.21 0.5
ROE 13.19 2.03
ROCE 17.15 3.6
Cash Conversion Cycle (days) -6.66 41

Valuation & price assessment

Q.1 Stock return of Novartis India Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 3.7% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 3.7% 11.3% 19.4% 21.9%
Q.3 Valuation ratios of Novartis India Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 25.39 0.00 21.75
Price to Book 3.12 2.19 1.55
Price to Sales 7.1 3.79 1.87
EV to EBITDA 13.53 18.89 13.67

Check more companies

1. Aditya Infotech
2. Aegis Logistics
3. Redington
4. RRP Semiconductor
5. Honasa Consumer
6. MMTC
7. Lloyds Enterprises
8. Cello World
9. Jeena Sikho Life
10. Elitecon Internation
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×